MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Tilray Inc

Closed

SectorHealthcare

0.61 -6.15

Overview

Share price change

24h

Current

Min

0.6

Max

0.65

Key metrics

By Trading Economics

Income

-46M

-85M

Sales

211M

EPS

-0.003

Profit margin

-40.456

Employees

2,650

EBITDA

-44M

-41M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+147.69% upside

Dividends

By Dow Jones

Next Earnings

8 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-600M

619M

Previous open

6.76

Previous close

0.61

News Sentiment

By Acuity

29%

71%

87 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Tilray Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 May 2024, 18:13 UTC

Major Market Movers

Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification

14 May 2024, 13:34 UTC

Earnings
Hot Stocks

Stocks to Watch Tuesday: AMC, GameStop, Alibaba, Home Depot -- WSJ

1 May 2024, 13:48 UTC

Hot Stocks

Stocks to Watch Wednesday: Starbucks, Pfizer, CVS, Amazon -- WSJ

Peer Comparison

Price change

Tilray Inc Forecast

Price Target

By TipRanks

147.69% upside

12 Months Forecast

Average 1.61 USD  147.69%

High 2.5 USD

Low 1 USD

Based on 8 Wall Street analysts offering 12 month price targets forTilray Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

2

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

0.6485 / 0.6586Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

No Evidence

Long Term

No Evidence

Sentiment

By Acuity

87 / 386 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Tilray Inc

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.